EUVIMEDEUVIMED entdecken
Crossref

Predictors of acute pancreatitis in patients treated with GLP-1 receptor agonists for weight management

Robert Postlethwaite, Amin M Amin, Rand Alsawas, Jaime P Almandoz, Tarek Sawas

Pancreatology · 2025-08 · 25 (5) · 609-613

DOI: 10.1016/j.pan.2025.06.018 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pancreatology, 2025-08. Verfasst von Robert Postlethwaite und 4 weiteren Autor:innen. Beteiligte Einrichtung: Division of Gastroenterology and Hepatology, University of Texas Medical Branch, Galveston, TX, USA. Hauptthemen laut MEDLINE: Pancreatitis, Glucagon-Like Peptide-1 Receptor Agonists, Obesity. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 21 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

INTRODUCTION: Glucagon-like peptide-1 receptor agonists (GLP-1RA) are widely prescribed for treating obesity and Type 2 Diabetes (T2D). There have been concerns that GLP-1RA is associated with acute pancreatitis (AP), although the data are controversial. We aimed to identify factors that impact the risk of AP after initiation of GLP-1RA treatment for obesity. METHODS: We performed a retrospective case-control study including adults patients initiated on a GLP-1RA for obesity management to determine risk factors associated with AP in obese patients taking GLP-1RA. We identified patients initiated on GLP-1RA. A multivariable logistic regression model was used to identify predictors of AP with GLP-1RA use. RESULTS: There were 2245 patients, of which 49 (2.2 %) developed AP after starting a GLP-1RA. A history of gallstone disease (adjusted odds ratio (aOR), 2.9 [95 % CI, 1.6 to 5.3]), history of AP (aOR 4.8 [CI, 1.8 to 13.2]), CAD/PVD (aOR 2 [CI, 1.01 to 3.9]) and tobacco use (aOR 2.4 [CI, 1.2 to 4.7]) were associated with a higher risk of AP with GLP-1RA use. Compared to a BMI ≤30 kg/m2, BMI categories 36-40 and > 40 were associated with a lower risk of AP with GLP-1RA therapy, (aOR 0.2 [CI, 0.06 to 0.6]) and (aOR 0.25 [CI, 0.09 to 0.68]), respectively. CONCLUSION: A history of gallstone disease, history of AP, CAD/PVD, and tobacco use were associated with AP after initiation of GLP-1RA for obesity treatment. A higher BMI appears to be protective against AP. Recognizing factors associated AP after GLP-1RA initiation can inform clinicians on risk stratification.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PancreatitisGlucagon-Like Peptide-1 Receptor AgonistsObesityHumansMaleFemaleMiddle AgedRetrospective StudiesCase-Control StudiesAdultRisk FactorsDiabetes Mellitus, Type 2AgedAcute DiseaseHypoglycemic Agents

Stichwörter der Autor:innen

Acute pancreatitisGlucagon-like peptide-1 receptor agonistsObesity

Substanzen

Glucagon-Like Peptide-1 Receptor AgonistsHypoglycemic Agents

Autor:innen und Institutionen

  • Division of Gastroenterology and Hepatology, University of Texas Medical Branch, Galveston, TX, USA.
  • Division of Digestive and Liver Diseases, University of Texas Southwestern, Dallas, TX, USA.
  • Division of Endocrinology, University of Texas Southwestern, Dallas, TX, USA.
  • Division of Digestive and Liver Diseases, University of Texas Southwestern, Dallas, TX, USA. Electronic address: tarek.sawas@UTsouthwestern.edu.

Zitieren

APA

Postlethwaite, R., Amin, A. M., Alsawas, R., Almandoz, J. P., & Sawas, T. (2025). Predictors of acute pancreatitis in patients treated with GLP-1 receptor agonists for weight management. Pancreatology, 25(5), 609-613. https://doi.org/10.1016/j.pan.2025.06.018

Vancouver

Postlethwaite R, Amin AM, Alsawas R, Almandoz JP, Sawas T. Predictors of acute pancreatitis in patients treated with GLP-1 receptor agonists for weight management. Pancreatology. 2025;25(5):609-613. doi:10.1016/j.pan.2025.06.018

BibTeX
@article{Postlethwaite2025,
  author = {Postlethwaite, Robert and Amin, Amin M and Alsawas, Rand and Almandoz, Jaime P and Sawas, Tarek},
  title = {Predictors of acute pancreatitis in patients treated with GLP-1 receptor agonists for weight management},
  journal = {Pancreatology},
  year = {2025},
  volume = {25},
  number = {5},
  pages = {609--613},
  doi = {10.1016/j.pan.2025.06.018}
}
Kostenlos starten →